sj-docx-1-tag-10.1177_17562848231151295 – Supplemental material for Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study

Autor: Eder, Piotr, Kłopocka, Maria, Cichoż-Lach, Halina, Talar-Wojnarowska, Renata, Kopertowska-Majchrzak, Maria, Michalak, Agata, Filip, Rafał, Waszak, Katarzyna, Stawczyk-Eder, Kamila, Janiak, Maria, Skrobot, Krzysztof, Liebert, Ariel, Zatorski, Hubert, Solarska-Półchłopek, Anna, Krogulecki, Michał, Pękała, Anna, Poniewierka, Elżbieta, Smoła, Izabela, Kaczka, Aleksandra, Wojciechowski, Krzysztof, Drygała, Szymon, Zagórowicz, Edyta

Supplemental material, sj-docx-1-tag-10.1177_17562848231151295 for Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c00e64dfef8e7189af47a70a902b36

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).

Autor: Liebert A; Department of Gastroenterology and Nutritional Disorders, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Kłopocka M; Department of Gastroenterology and Nutritional Disorders, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Michalak A; Department of Gastroenterology, Medical University of Lublin, Lublin, Poland., Cichoz-Lach H; Department of Gastroenterology, Medical University of Lublin, Lublin, Poland., Talar-Wojnarowska R; Department of Digestive Tract Diseases, Medical University of Łódź, Łódź, Poland., Domz Ał-Magrowska D; Department of Digestive Tract Diseases, Medical University of Łódź, Łódź, Poland., Konecki Ł; Department of Gastroenterology, Military Institute of Medicine, Warsaw, Poland., Filipiuk A; Department of Gastroenterology, Military Institute of Medicine, Warsaw, Poland., Krogulecki M; Department of Gastroenterology, Military Institute of Medicine, Warsaw, Poland., Kopertowska-Majchrzak M; Department of Internal Diseases, General Hospital, Mie˛dzychód, Poland., Stawczyk-Eder K; Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University Clinical Hospital, Poznań University of Medical Sciences, Poznań, Poland., Waszak K; Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University Clinical Hospital, Poznań University of Medical Sciences, Poznań, Poland., Eder P; Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University Clinical Hospital, Poznań University of Medical Sciences, Poznań, Poland., Zagórowicz E; Department of Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center of Postgraduate Education, Warsaw, Poland., Smoła I; Department and Clinic of Gastroenterology, Hepatology and Internal Medicine, Faculty of Medicine, Wrocław Medical University, Wrocław, Poland., Wojciechowski K; Department of Internal Diseases, The Independent Public Health Care Center, Tarczyn, Poland., Drygała S; Szymon Drygała Takeda Pharma Sp. z.o.o., St. Prosta 68, Warsaw, Mazovia Province 00-838, Poland.

Publikováno v: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2024 Nov 20; Vol. 17, pp. 17562848241293938. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).